Legal entity
Every one of those 1 sits in a single category, regulation. Of the tracked stories, 1 of 1 also mention Drug Enforcement Administration (DEA), the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.6 for the broader beat in this window.
Last mentioned: Jul 27, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, regulation. Of the tracked stories, 1 of 1 also mention Drug Enforcement Administration (DEA), the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.6 for the broader beat in this window. At 6, the average consequence score sits below the same-window beat average of 6.1. We currently track 1 Legal story that mention MMJ BioPharma Labs, Inc., all published on July 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering MMJ BioPharma Labs, Inc.. Shared-story counts are live from our verified record — not editorial picks.
The MMJ International Holdings petition raises fundamental administrative law questions: can an agency issue a final rescheduling order before conducting the hearing required by the Controlled Substances Act? The D.C. Circuit’s answer will shape DEA’s authority over all future scheduling actions.
MMJ BioPharma Labs, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
